1. Home
  2. ITRN vs SVRA Comparison

ITRN vs SVRA Comparison

Compare ITRN & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ituran Location and Control Ltd.

ITRN

Ituran Location and Control Ltd.

HOLD

Current Price

$50.75

Market Cap

881.7M

Sector

Technology

ML Signal

HOLD

SVRA

Savara Inc.

HOLD

Current Price

$5.07

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRN
SVRA
Founded
1994
2007
Country
Israel
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
881.7M
1.0B
IPO Year
2005
2009

Fundamental Metrics

Financial Performance
Metric
ITRN
SVRA
Price
$50.75
$5.07
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$62.50
$7.33
AVG Volume (30 Days)
88.5K
1.5M
Earning Date
03-05-2026
03-13-2026
Dividend Yield
4.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.38
N/A
Revenue Next Year
$8.21
$430.87
P/E Ratio
$16.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.23
$1.89
52 Week High
$51.76
$7.01

Technical Indicators

Market Signals
Indicator
ITRN
SVRA
Relative Strength Index (RSI) 58.82 40.25
Support Level $34.52 $3.36
Resistance Level N/A $6.10
Average True Range (ATR) 1.89 0.26
MACD -0.00 -0.05
Stochastic Oscillator 92.21 19.79

Price Performance

Historical Comparison
ITRN
SVRA

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: